| 101 |
19363466 | Paclitaxel combined with siRNA targeting HPV16 oncogenes improves cytotoxicity for cervical carcinoma. | 2009 Oct |
1 |
| 102 |
19397590 | Arsenic trioxide suppresses paclitaxel-induced mitotic arrest. | 2009 Jun |
1 |
| 103 |
19421315 | MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel. | 2009 |
2 |
| 104 |
19815708 | The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy. | 2009 Nov |
1 |
| 105 |
17960385 | The effect of p53 gene expression on the inhibition of cell proliferation by paclitaxel. | 2008 Aug |
4 |
| 106 |
18158619 | Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells. | 2008 Nov |
1 |
| 107 |
18205918 | Quantitative image analysis of intra-tumoral bFGF level as a molecular marker of paclitaxel resistance. | 2008 Jan 18 |
1 |
| 108 |
18319335 | Modulation of drug resistance by artificial transcription factors. | 2008 Mar |
1 |
| 109 |
18469851 | Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis. | 2008 Jul 24 |
2 |
| 110 |
18506998 | Adenovirus-mediated inhibitor kappaB gene transfer improves the chemosensitivity to anticancer drugs in human lung cancer in vitro and in vivo. | 2008 Mar-Apr |
1 |
| 111 |
18516295 | Cyclic pifithrin-alpha sensitizes wild type p53 tumor cells to antimicrotubule agent-induced apoptosis. | 2008 Jun |
3 |
| 112 |
18555006 | p19(ras) amplifies p73beta-induced apoptosis through mitochondrial pathway. | 2008 Aug 15 |
1 |
| 113 |
18806740 | Differential effects of low and high doses of Taxol in anaplastic thyroid cancer cells: possible implication of the Pin1 prolyl isomerase. | 2008 Sep |
1 |
| 114 |
18813780 | Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1. | 2008 Oct |
1 |
| 115 |
18971636 | RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53. | 2008 Nov 1 |
1 |
| 116 |
19000447 | [Correlation of expression of P-glycoprotein and inhibitor of apoptosis proteins to chemosensitivity in gastrointestinal carcinoma tissues]. | 2008 Nov |
1 |
| 117 |
20731894 | [Effects of p53 gene on drug resistance in human lung cancer cell lines.]. | 2008 Apr 20 |
1 |
| 118 |
17244262 | Additive cytotoxic effect of apoptin and chemotherapeutic agents paclitaxel and etoposide on human tumour cells. | 2007 Feb |
3 |
| 119 |
17636258 | Activation of targeted necrosis by a p53 peptide: a novel death pathway that circumvents apoptotic resistance. | 2007 Sep 14 |
1 |
| 120 |
17686239 | [The predictive factors for the response to platinum/paclitaxel based first-line adjuvant chemotherapy in advanced ovarian cancer]. | 2007 May 8 |
1 |
| 121 |
17823933 | Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway. | 2007 Nov 1 |
6 |
| 122 |
17912033 | Replication stress, defective S-phase checkpoint and increased death in Plk2-deficient human cancer cells. | 2007 Oct 15 |
1 |
| 123 |
18231754 | The relationship between p38MAPK and apoptosis during paclitaxel resistance of ovarian cancer cells. | 2007 Dec |
1 |
| 124 |
15990222 | Induction of p53 and drug resistance following treatment with cisplatin or paclitaxel in ovarian cancer cell lines. | 2006 May 18 |
2 |
| 125 |
16356831 | 2-Methoxyestradiol and paclitaxel have similar effects on the cell cycle and induction of apoptosis in prostate cancer cells. | 2006 Jan 8 |
1 |
| 126 |
16364249 | TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer. | 2006 Feb 3 |
1 |
| 127 |
16459017 | Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin. | 2006 Sep 28 |
1 |
| 128 |
16616141 | Evidence that low doses of Taxol enhance the functional transactivatory properties of p53 on p21 waf promoter in MCF-7 breast cancer cells. | 2006 Apr 17 |
3 |
| 129 |
16687915 | Prolonged mitosis versus tetraploid checkpoint: how p53 measures the duration of mitosis. | 2006 May |
1 |
| 130 |
16739339 | P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome. | 2006 Jan-Feb |
2 |
| 131 |
16820892 | Growth inhibition and apoptosis induction in ovarian cancer cells. | 2006 Aug |
1 |
| 132 |
17166391 | [Routine chemotherapeutic drug treatment effectiveness predictive molecules and chemotherapeutic drug selection]. | 2006 Dec |
1 |
| 133 |
15592521 | A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway. | 2005 Jan 27 |
2 |
| 134 |
15657900 | Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity. | 2005 May 20 |
2 |
| 135 |
15662138 | The tumor suppressor p33ING1b enhances taxol-induced apoptosis by p53-dependent pathway in human osteosarcoma U2OS cells. | 2005 Jan |
3 |
| 136 |
15691646 | Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy. | 2005 Feb |
1 |
| 137 |
15711598 | Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim. | 2005 Mar |
1 |
| 138 |
15746064 | Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivo. | 2005 Feb 15 |
1 |
| 139 |
15863265 | Paclitaxel/Taxol sensitivity in human renal cell carcinoma is not determined by the p53 status. | 2005 May 26 |
2 |
| 140 |
15870870 | Apoptosis induced by 5-fluorouracil, cisplatin and paclitaxel are associated with p53 gene status in gastric cancer cell lines. | 2005 Jun |
3 |
| 141 |
15908516 | Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs. | 2005 Aug |
1 |
| 142 |
16122187 | Relationship between chemotherapy with paclitaxel, cisplatin, vinorelbine and titanocene dichloride and expression of proliferation markers and tumour suppressor gene p53 in human ovarian cancer xenografts in nude mice. | 2005 |
1 |
| 143 |
16127286 | p53 Gene status and response to topotecan-containing chemotherapy in advanced ovarian carcinoma. | 2005 |
1 |
| 144 |
15012603 | Regulation of estrogen receptor-alpha expression in MCF-7 cells by taxol. | 2004 Mar |
1 |
| 145 |
15031599 | Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone. | 2004 |
1 |
| 146 |
15159015 | Insulin can modulate MCF-7 cell response to paclitaxel. | 2004 Jun 25 |
1 |
| 147 |
15467449 | The cyclin-dependent kinase inhibitor p21(CIP1/WAF1) blocks paclitaxel-induced G2M arrest and attenuates mitochondrial injury and apoptosis in p53-null human leukemia cells. | 2004 Oct |
1 |
| 148 |
15475475 | High-content screening with siRNA optimizes a cell biological approach to drug discovery: defining the role of P53 activation in the cellular response to anticancer drugs. | 2004 Oct |
1 |
| 149 |
15486197 | Antiangiogenic activity of paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway. | 2004 Oct |
1 |
| 150 |
12518324 | Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms. | 2003 Feb 15 |
1 |